SCHEMBL7412400

SCHEMBL7412400

O=C1Cc2c(ccc3c2OC=CO3)N1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.36
DRD4 P21917 4/20 0.36
DRD3 P35462 4/20 0.36
ADRA1A P35348 3/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
CHRM2 P08172 1/20 0.36
CYP3A4 P08684 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ADRA2B P18089 1/20 0.36
DRD1 P21728 1/20 0.36
DRD5 P21918 1/20 0.36
HTR2A P28223 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
HRH1 P35367 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835971 0.77 POLB (0.41) DRD2DRD4DRD3ADRA1AKDM4E
SCHEMBL4786408 0.77 DRD2 (0.37) DRD2DRD4DRD3ADRA1AHTR2A
SCHEMBL18289479 0.76 AHR (0.50) DRD2DRD4DRD3ADRA1AKDM4E
SCHEMBL13243255 0.70 DRD2 (0.42) DRD2DRD4DRD3ADRA1AHTR2A
SCHEMBL3032145 0.70 DRD2 (0.42) DRD2DRD4DRD3ADRA1AHTR2A
SCHEMBL10305227 0.70 CREBBP (0.40) DRD2DRD4DRD3ADRA1AHTR2A
SCHEMBL5519398 0.69
SCHEMBL8122818 0.67 DRD2 (0.42) DRD2DRD4DRD3ADRA1AHTR2A
SCHEMBL3026960 0.67 DRD2 (0.42) DRD2DRD4DRD3ADRA1AHTR2A
SCHEMBL13222379 0.67 DRD2 (0.42) DRD2DRD4DRD3ADRA1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235570-A2 COMBINATIONS OF (S)-2-(BENZYLAMINO-METHYL)-2,3,8,9,-TETRAHYDRO-7H-1,4-DIOXINO(2,3)-E INDOL-8-ONE AND NEUROLEPTICS Wyeth (US) 2002-09-04 EP disclosed
WO-2001041750-A2 COMBINATIONS OF (S)-2-(BENZYLAMINO-METHYL)-2,3,8,9,-TETRAHYDRO-7H-1,4-DIOXINO(2,3)-E INDOL-8-ONE AND NEUROLEPTICS WYETH (US) 2001-06-14 WO disclosed